1. Epidermal growth factor receptor and anaplastic lymphoma kinase testing and mutation prevalence in patients with advanced non‐small cell lung cancer in Switzerland: A comprehensive evaluation of real world practices. (30th May 2017) Authors: Ess, S.M.; Herrmann, C.; Frick, H.; Krapf, M.; Cerny, T.; Jochum, W.; Früh, M. Journal: European journal of cancer care Issue: Volume 26:Number 6(2017:Nov.) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Genomic profiling of late‐onset basal cell carcinomas from two brothers with nevoid basal cell carcinoma syndrome. (23rd July 2020) Authors: Hasan Ali, O.; Yurchenko, A.A.; Pavlova, O.; Sartori, A.; Bomze, D.; Higgins, R.; Ring, S.S.; Hartmann, F.; Bühler, D.; Fritzsche, F.R.; Jochum, W.; Navarini, A.A.; Kim, A.; French, L.E.; Dermitzakis, E.; Christiano, A.M.; Hohl, D.; Bickers, D.R.; Nikolaev, S.I.; Flatz, L. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 2(2021) Page Start: 396 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Individualized treatment approaches for Langerhans cell histiocytosis. (1st June 2018) Authors: Roider, E.; Signer, C.; Fehrenbacher, B.; Metzler, G.; Schaller, M.; Kamarachev, J.; Kerl, K.; Balabanov, S.; Jochum, W.; Hoetzenecker, W.; Cozzio, A.; French, L.E.; Dummer, R.; Guenova, E. Journal: British journal of dermatology Issue: Volume 178:Number 6(2018) Page Start: 1423 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Individualized treatment approaches for Langerhans cell histiocytosis. (23rd March 2018) Authors: Roider, E.; Signer, C.; Fehrenbacher, B.; Metzler, G.; Schaller, M.; Kamarachev, J.; Kerl, K.; Balabanov, S.; Jochum, W.; Hoetzenecker, W.; Cozzio, A.; French, L.E.; Dummer, R.; Guenova, E. Journal: British journal of dermatology Issue: Volume 178:Number 6(2018) Page Start: 1423 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P1053: ALBUMIN AND C-REACTIVE PROTEIN PROVIDE PROGNOSTIC INFORMATION INDEPENDENTLY FROM MIPSS70 IN OVERT MYELOFIBROSIS. A RETROSPECTIVE STUDY. (23rd June 2022) Authors: Messerich, N.-M.; Volken, T.; Cogliatti, S.; Lehmann, T.; Holbro, A.; Demmer, I.; Benz, R.; Jochum, W.; Silzle, T. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 943 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Patterns of progression on osimertinib in EGFR T790M positive NSCLC: A Swiss cohort study. (April 2019) Authors: Schmid, S.; Klingbiel, D.; Aeppli, S.; Britschgi, C.; Gautschi, O.; Pless, M.; Rothschild, S.; Wannesson, L.; Janthur, W.; Foerbs, D.; Demmer, I.; Jochum, W.; Früh, M. Journal: Lung cancer Issue: Volume 130(2019) Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PB2060: THE MDS-SPECIFIC COMORBIDITY INDEX (MDS-CI) PREDICTS SURVIVAL INDEPENDENTLY FROM DIPSS AND MIPSS70 IN PATIENTS WITH OVERT MYELOFIBROSIS NOT ELIGIBLE FOR ALLOGENEIC STEM CELL TRANSPLANTATION. (23rd June 2022) Authors: Koster, K.-L.; Messerich, N.-M.; Volken, T.; Cogliatti, S.; Lehmann, T.; Holbro, A.; Benz, R.; Graf, L.; Demmer, I.; Jochum, W.; Silzle, T. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1931 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PO-106: Prognostic significance of cyclin D1 and pRb expression in oropharyngeal carcinoma. (March 2017) Authors: Broglie, M.A.; Plath, M.M.; Stoeckli, S.J.; Jochum, W. Journal: Radiotherapy and oncology Issue: Volume 122(2017)Supplement 1 Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗